Cancer vaccine - Ferring Pharmaceuticals

Drug Profile

Cancer vaccine - Ferring Pharmaceuticals

Alternative Names: Fibrovax

Latest Information Update: 03 Sep 2012

Price : $50

At a glance

  • Originator Cytokine PharmaSciences
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
  • 03 Sep 2012 No development reported - Phase-I for Cancer in USA (Injection)
  • 18 Jul 2000 Cytokine Networks is now called Cytokine PharmaSciences
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top